Trials / Completed
CompletedNCT00269074
Effect of IDEA-070 on Pain and Inflammation Induced by PDT
Safety and Efficacy of IDEA-070 for the Treatment of Pain and Inflammation Induced by Photodynamic Therapy of Actinic Keratosis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 24 (planned)
- Sponsor
- IDEA AG · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Primary objectives: effect of IDEA-070 compared to placebo on pain and inflammation induced by PDT. The primary objective is to detect a statistically significant difference of pain and inflammation induced by PDT in test areas treated with IDEA-070 compared to placebo-treated areas.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IDEA-070 |
Timeline
- Start date
- 2006-01-01
- Completion
- 2006-07-01
- First posted
- 2005-12-23
- Last updated
- 2009-03-20
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00269074. Inclusion in this directory is not an endorsement.